These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1231 related items for PubMed ID: 24068440

  • 1. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R, Zubor P, Janusicova V, Visnovsky J, Mendelova A, Kajo K, Lasabova Z, Plank L, Danko J.
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [Abstract] [Full Text] [Related]

  • 2. Hypermethylation of selected genes in endometrial carcinogenesis.
    Visnovsky J, Fiolka R, Kudela E, Slavik P, Krkoska M, Lasabová Z, Danko J.
    Neuro Endocrinol Lett; 2013 Dec; 34(7):675-80. PubMed ID: 24464006
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
    Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Müller SC, von Ruecker A.
    Clin Cancer Res; 2005 Jun 01; 11(11):4097-106. PubMed ID: 15930345
    [Abstract] [Full Text] [Related]

  • 4. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
    Arafa M, Kridelka F, Mathias V, Vanbellinghen JF, Renard I, Foidart JM, Boniver J, Delvenne P.
    Histopathology; 2008 Nov 01; 53(5):525-32. PubMed ID: 18783461
    [Abstract] [Full Text] [Related]

  • 5. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z, Zhang H, Yang J, Hao T, Li S.
    Cell Biol Int; 2012 May 01; 36(5):427-32. PubMed ID: 21864295
    [Abstract] [Full Text] [Related]

  • 6. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T.
    Lung Cancer; 2007 Oct 01; 58(1):131-8. PubMed ID: 17606310
    [Abstract] [Full Text] [Related]

  • 7. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
    Mao WM, Li P, Zheng QQ, Wang CC, Ge MH, Hu FJ, Fang XH, Dong ZM, Ling ZQ.
    Arch Med Res; 2011 Apr 01; 42(3):182-8. PubMed ID: 21722812
    [Abstract] [Full Text] [Related]

  • 8. p16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner.
    Su PF, Huang WL, Wu HT, Wu CH, Liu TY, Kao SY.
    Oral Oncol; 2010 Oct 01; 46(10):734-9. PubMed ID: 20729138
    [Abstract] [Full Text] [Related]

  • 9. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
    Liao X, Siu MK, Chan KY, Wong ES, Ngan HY, Chan QK, Li AS, Khoo US, Cheung AN.
    Int J Cancer; 2008 Jul 15; 123(2):296-302. PubMed ID: 18404674
    [Abstract] [Full Text] [Related]

  • 10. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
    Reibenwein J, Pils D, Horak P, Tomicek B, Goldner G, Worel N, Elandt K, Krainer M.
    Prostate; 2007 Mar 01; 67(4):427-32. PubMed ID: 17192910
    [Abstract] [Full Text] [Related]

  • 11. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO.
    Clin Cancer Res; 2005 Aug 01; 11(15):5365-9. PubMed ID: 16061849
    [Abstract] [Full Text] [Related]

  • 12. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
    Yamamoto N, Nakayama T, Kajita M, Miyake T, Iwamoto T, Kim SJ, Sakai A, Ishihara H, Tamaki Y, Noguchi S.
    Breast Cancer Res Treat; 2012 Feb 01; 132(1):165-73. PubMed ID: 21594664
    [Abstract] [Full Text] [Related]

  • 13. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
    Sebova K, Zmetakova I, Bella V, Kajo K, Stankovicova I, Kajabova V, Krivulcik T, Lasabova Z, Tomka M, Galbavy S, Fridrichova I.
    Cancer Biomark; 2012 Feb 01; 10(1):13-26. PubMed ID: 22297548
    [Abstract] [Full Text] [Related]

  • 14. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.
    Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, Kang GH.
    Am J Pathol; 2003 Oct 01; 163(4):1371-8. PubMed ID: 14507645
    [Abstract] [Full Text] [Related]

  • 15. Promoter hypermethylation profile of kidney cancer.
    Dulaimi E, Ibanez de Caceres I, Uzzo RG, Al-Saleem T, Greenberg RE, Polascik TJ, Babb JS, Grizzle WE, Cairns P.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):3972-9. PubMed ID: 15217927
    [Abstract] [Full Text] [Related]

  • 16. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H, Geeraerts H, Verbeken E, Nuyts S.
    Oncol Rep; 2009 Feb 15; 21(2):507-13. PubMed ID: 19148529
    [Abstract] [Full Text] [Related]

  • 17. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS, Chae Y, Ha YS, Kim IY, Byun SS, Yun SJ, Kim WJ.
    Clin Genitourin Cancer; 2012 Jun 15; 10(2):114-20. PubMed ID: 22382007
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R.
    Life Sci; 2010 Jul 17; 87(3-4):83-91. PubMed ID: 20470789
    [Abstract] [Full Text] [Related]

  • 19. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM.
    Mol Carcinog; 2002 Oct 17; 35(2):85-92. PubMed ID: 12325038
    [Abstract] [Full Text] [Related]

  • 20. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
    Singal R, Ferdinand L, Reis IM, Schlesselman JJ.
    Oncol Rep; 2004 Sep 17; 12(3):631-7. PubMed ID: 15289848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.